Merx #SN25006

Acquisition of Comprehensive Drug Pricing and Utilization Database for PMPRB

The Patented Medicine Prices Review Board (PMPRB), a Canadian federal agency, is seeking to acquire a comprehensive database for drug pricing and utilization analysis. - Government Buyer: - Patented Medicine Prices Review Board (PMPRB), Canada - Products/Services Requested: - Existing, fully developed database covering drug utilization data for both retail and hospital sectors - Database must include: - Market variables: prices (ex-factory, wholesale, retail) in local and US currency - Quantities and revenue of medicines sold in Canada and all OECD countries - Data collected objectively and non-biased from hospitals, pharmacies, and wholesalers - Disease and patient functionality - OEMs and Vendors: - No specific OEMs or vendors are named in the notice - Unique or Notable Requirements: - Database must be ready-to-use (not under development) - Must provide comprehensive coverage for Canada and all OECD countries - Data must be collected from multiple sources (hospitals, pharmacies, wholesalers) and be objective - Supports PMPRB's mandate to monitor patented medicine prices and analyze pharmaceutical market trends

Description

The Patented Medicine Prices Review Board (PMPRB) seeks to procure an existing, fully developed database containing drug utilization data for retail and hospital sectors. The database must include relevant market variables such as prices at various levels, quantities, and revenue of medicines sold in Canada and OECD countries. The data should be collected objectively and non-biased from hospitals, pharmacies, and wholesalers. This procurement supports PMPRB's role in monitoring patented medicine prices and contributing to pharmaceutical trend analysis.

View original listing